Identification of Neutralizing Anti-HMGB1 IgM Autoantibody and Its B Cell Producers
نویسندگان
چکیده
Abstract Extracellular High Mobility Group Box 1 (HMGB1) is a prototypic damage-associated molecular pattern (DAMP). While homeostatic level of extracellular HMGB1 may be beneficial for immune defense, tissue repair and regeneration, excessive linked to chronic inflammation inflammatory diseases. This prompts an intriguing question: How does healthy body control the HMGB1? Here we have identified, in plasma both humans mice, anti-HMGB1 IgM autoantibody that neutralizes via binding specifically 100% conserved epitope, namely HMW4 (HMGB1 98–112). In this (i.e., anti-HMW4 IgM) produced by peritoneal B-1 cells, concomitant triggering their B cell receptor toll-like 4 stimulates production IgM. The ability induce its own neutralizing antibody suggests feedback loop limiting DAMP body. Currently, our studies are ongoing identify characterize human counterpart cells produce IgM, first amplifying HMW4-reactive from peripheral blood mononuclear (PBMCs) NSG recipient presence cell-stimulating adjuvants (such as mitogens). These serve prelude exploring down road treating patients with diseases provide insight pertaining role regulation other molecules.
منابع مشابه
Anti-HMGB1 Neutralizing Antibody Ameliorates Neutrophilic Airway Inflammation by Suppressing Dendritic Cell-Mediated Th17 Polarization
We demonstrate that high mobility group box 1 protein (HMGB1) directs Th17 skewing by regulating dendritic cell (DC) function. First, our in vitro studies reveal that recombinant HMGB1 (rHMGB1) activates myeloid DCs to produce IL-23 in vitro, and rHMGB1-activated DCs prime naïve lymphocytes to produce the Th17 cytokine IL-17A. Second, we demonstrate that anti-HMGB1 neutralizing antibody attenua...
متن کاملHuman leukemic B cell activation: functional consequence of membrane IgM interaction with anti-IgM ligand is an alterable cell characteristic.
A functional study of several human malignant B cell populations has indicated that occasional leukemic clones are extraordinarily sensitive to signal transduction through membrane IgM. One isolated hairy cell leukemia (HCL) with low background DNA synthesis was stimulated to significant levels of DNA synthesis when cultured with high (100 micrograms/mL) concentrations of soluble anti-IgM ligan...
متن کاملObinutuzumab, a potent anti–B-cell agent, for rituximab-unresponsive IgM anti-MAG neuropathy
We describe clinical response and autoantibody changes after treatment with obinutuzumab (Gazyva), a new generation of humanized anti-CD20 monoclonal antibodies, in 2 patients with anti-MAG neuropathy who continued to worsen despite multiple courses of rituximab. Obinutuzumab, approved for chronic lymphocytic leukemia (CLL), exerts greater peripheral and lymphoid B-cell depletion and might be m...
متن کاملHuman B-cell differentiation factor defined by an anti-peptide antibody and its possible role in autoantibody production.
The partial amino acid sequence of the NH2 terminus of a factor named human B-cell differentiation factor or B-cell stimulatory factor 2 (BSF-2) has been determined. Antibodies raised against the synthetic peptide corresponding to residues 1-13 of the NH2-terminal sequence specifically react with BSF-2 generated by a T-cell line and by phytohemagglutinin-stimulated normal T cells. Furthermore, ...
متن کاملAnti-IgM-mediated B cell signaling. Molecular analysis of ligand binding requisites for human B cell clonal expansion and tolerance
The ligand binding requisites for membrane IgM-mediated signaling of human B lymphocyte clonal expansion and B cell tolerance were investigated with a well-characterized set of soluble murine anti-human IgM mAbs. Evaluation of the impact of mu chain domain specificity, affinity, and binding stoichiometry for membrane IgM on antibody-induced regulation of normal and leukemic B cell DNA synthesis...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Journal of Immunology
سال: 2023
ISSN: ['1550-6606', '0022-1767']
DOI: https://doi.org/10.4049/jimmunol.210.supp.83.15